• Type:
  • Category:

BRAIN Biotech AG Financial Results 9M 2021/ 22 | Unveiling the Future with IR

Share

BRAIN Biotech AG 9M 2021/22: Key Takeaways

Introduction to Brain’s Financials Q3-2022 Presentation

This video features Michael Schneiders, Head of Investor Relations at Brain Biotech AG.

 

Join us as Michael takes us through Brain’s Financials Q3-2022 Presentation. He will cover a range of topics, including Brain’s core values, their commitment to ESG and sustainability, Q3 highlights and lowlights, incubator exits, PHA121, the Brain incubator, financial highlights for 9M 2021/22, cash and cash flow, long-term revenue growth trajectory, risks related to supply chain and inflation, and FY21/22 guidance and mid-term targets.

 

So sit back, relax, and let Michael guide you through Brain’s latest developments.

 

Key Topics Covered in the Presentation

Brain’s Core Values and ESG Commitment

 

Q3-2022 Highlights and Lowlights

 

Incubator Exits and PHA121

 

Financial Highlights for 9M 2021/22

 

Risks Related to Supply Chain and Inflation

 

FY21/22 Guidance and Mid-Term Targets

Chapters
  • Brain at a Glance
  • Brain Core Values
  • ESG / Sustainability
  • Q3-Highlights / Lowlights
  • Incubator Exits
  • PHA121
  • Brain Incubator
  • 9M 2021/22 Financial Highlights
  • Cash & Cash Flow
  • Long-Term Revenue Growth Trajectory
  • Risks: Supply Chain and Inflation
  • FY21/22 Guidance, Mid-Term Targets
Resources
Presentation
BRAIN Biotech Video Hub
Podcast
Host
michaelschneiders - BRAIN Biotech AG Financial Results 9M 2021/ 22 | Unveiling the Future with IR -%sitename%

Michael Schneiders
CFO | BRAIN Biotech AG​

Linkedin Envelope
Share
T&C:

This publication is for informational purposes only and should not be considered investment advice. By using this website, you agree to the terms and conditions outlined in the legal pages at www.seat11a.com/legal/

Continuing the Journey: More Presentations

Discover Additional Elevator Pitches

Release Date

August 29, 2022

Duration

14:30

Director

Reviews for BRAIN Biotech AG Financial Results 9M 2021/ 22 | Unveiling the Future with IR
There are currently no reviews for BRAIN Biotech AG Financial Results 9M 2021/ 22 | Unveiling the Future with IR
COMPANIES:

Germany:

Austria:

Estonia:

Finland:

France:

Italy:

Poland:

Spain:

PRESENTATIONS:
INDUSTRIES:
Linkedin Twitter Instagram Podcast Envelope Whatsapp

(c) seat11a – Publicly Listed Companies: Elevator Pitch, Deep-Dive, Financial Results, and ESG 

Unlock the insights of top publicly listed companies with seat11a.com

Elevate your understanding with powerful Elevator Pitches, Deep-Dive Presentations, and in-depth Financial Analysis

Scroll to top